COVID-19

Stopping some doctors from sharing unsound medical advice has proved challenging. Even defining misinformation has been difficult. And during the pandemic, resistance from some state legislatures is complicating the effort.

The NVX-CoV2373 vaccine was evaluated in adolescents aged 12 to 17 years.

The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.

Get the Facts. Get Vaccinated.

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.

The research team found that levels of depression are at least 3 times higher than before the COVID-19 pandemic.

The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy.

Study results show that fetal cognitive development in the assessed areas was age-appropriate and there was no indication of infection.

COVID-19 updates and news to know as of January 17, 2022.

Employee mandate would have impacted 84 million workers. Health care mandate affects every facility that receives federal funding.

Do no harm, even though your patient might.

A study published January 6, 2022 showed that COVID-19 vaccinations may temporarily cause changes to the timing of menstruation.

The Society for Maternal-Fetal Medicine has published an update for provider considerations for COVID-19 vaccine counseling with pregnant or lactating patients.

The moves bring two new weapons to the toolbox for physicians fighting the pandemic.

Pregnant? Thinking about pregnancy? Recently pregnant? Check out the top 5 reasons to get the COVID-19 vaccine from the Society for Maternal-Fetal Medicine.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

Blood clot risk in J&J higher for women, draws CDC concerns

COVIDmenses is recruiting participants for a study to examine potential effects of COVID-19 vaccination on menstrual health.

An update from infectious disease expert, Rana F. Hamdy, MD, on the Omicron variant of COVID-19.

The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.

The AMA continues its fight against COVID-19 disinformation generated by physicians with a new policy.

Disparities across the globe continue to surface as we approach year 2 of the COVID-19 pandemic, especially in health care. As one considers its implications, a research team from the American Cancer Society investigated its potential impact on early cancer detection.

The next step in the approval process is the formal acceptance of the recommendation by CDC Director Rochelle P. Walensky, MD, MPH.

The US Food and Drug Administration (FDA) has amended the emergency use authorization of the Pfizer/BioNTech vaccine to include children aged 5 to 11 years.

The advisory panel is also scheduled to discuss Merck antiviral pill late next month.